Clinical Trial

A Multicenter, Randomized, Double-Blind, Controlled Clinical Study of Minocycline for the Treatment of Retinitis Pigmentosa

Name: A Multicenter, Randomized, Double-Blind, Controlled Clinical Study of Minocycline for the Treatment of Retinitis Pigmentosa — clinical trial record (NCT07082855)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This is a multicenter, double-blind, randomized controlled clinical trial to get high - level evidence on minocycline's efficacy and safety（100mg/d, 200mg/d) for Retinitis pigmentosa and to find the optimal treatment dose.

Trial Details

NCT Number	NCT07082855
Lead Sponsor	Zhongshan Ophthalmic Center, Sun Yat-sen University
Conditions	Retinitis Pigmentosa, Inherited Retinal Dystrophy, Retina Disorder
Enrollment	126 participants
Start Date	2025-07-15
Primary Completion	2028-02-28 (estimated)
Study Completion	2028-06-30 (estimated)
Updated on ClinicalTrials.gov	2025-07-24